 Predictive Value of Tests
"Predictive Value of Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
| Descriptor ID |
D011237
|
| MeSH Number(s) |
E05.318.780.800.650 N05.715.360.780.700.640 N06.850.520.445.800.650
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Predictive Value of Tests".
Below are MeSH descriptors whose meaning is more specific than "Predictive Value of Tests".
This graph shows the total number of publications written about "Predictive Value of Tests" by people in this website by year, and whether "Predictive Value of Tests" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 4 | 4 | | 1996 | 0 | 6 | 6 | | 1997 | 0 | 11 | 11 | | 1998 | 0 | 12 | 12 | | 1999 | 0 | 14 | 14 | | 2000 | 0 | 12 | 12 | | 2001 | 0 | 20 | 20 | | 2002 | 0 | 24 | 24 | | 2003 | 0 | 35 | 35 | | 2004 | 1 | 39 | 40 | | 2005 | 1 | 40 | 41 | | 2006 | 1 | 39 | 40 | | 2007 | 1 | 47 | 48 | | 2008 | 2 | 65 | 67 | | 2009 | 1 | 68 | 69 | | 2010 | 1 | 74 | 75 | | 2011 | 0 | 73 | 73 | | 2012 | 0 | 72 | 72 | | 2013 | 0 | 79 | 79 | | 2014 | 1 | 80 | 81 | | 2015 | 0 | 108 | 108 | | 2016 | 1 | 63 | 64 | | 2017 | 1 | 61 | 62 | | 2018 | 0 | 72 | 72 | | 2019 | 0 | 67 | 67 | | 2020 | 1 | 57 | 58 | | 2021 | 1 | 44 | 45 | | 2022 | 1 | 24 | 25 | | 2023 | 0 | 14 | 14 | | 2024 | 8 | 37 | 45 | | 2025 | 0 | 9 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Predictive Value of Tests" by people in Profiles.
-
Lalani C, Medina F, Oseran AS, Liang L, Song Y, Butala NM, Kazi DS, Cohen DJ, Strom JB, Wadhera RK, Yeh RW. Validation of Medicare Advantage Claims for Long-Term Outcome Assessment in Low-Risk Aortic Valve Replacement. Circ Cardiovasc Qual Outcomes. 2025 May; 18(5):e011991.
-
Rashidian P, Parsaei M, Hantoushzadeh S, Salmanian B. Investigating the association of albuminuria with the incidence of preeclampsia and its predictive capabilities: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2025 Mar 20; 25(1):322.
-
Smith MD, April MD, Schauer SG, Rizzo JA. Repeat Bronchoscopies Are Poorly Predictive of Outcomes Following Inhalation Injury. J Burn Care Res. 2025 Mar 04; 46(2):271-275.
-
Soszyn N, Minocha PK, Frank B, Mejia E, Zablah JE, Morgan GJ. Impact of echocardiographic and computed-tomography assessment of Sano shunt stenosis on need for percutaneous intervention. Int J Cardiovasc Imaging. 2025 May; 41(5):859-868.
-
Akabane M, Kawashima J, Altaf A, Woldesenbet S, Cauchy F, Aucejo F, Popescu I, Kitago M, Martel G, Ratti F, Aldrighetti L, Poultsides GA, Imaoka Y, Ruzzenente A, Endo I, Gleisner A, Marques HP, Lam V, Hugh T, Bhimani N, Shen F, Pawlik TM. Development and validation of the albumin-bilirubin gamma-glutamyl transferase score for enhanced prognostic accuracy after hepatocellular carcinoma resection. J Gastrointest Surg. 2025 Apr; 29(4):101984.
-
Nandakumar V, Braun KMP, Willrich MAV. Challenges for complement functional assays in the clinical laboratory: From test validation to clinical interpretation. J Immunol Methods. 2025 Feb; 537:113824.
-
Furuta EJM, Atkins D, Furuta GT. Diagnosing eosinophilic esophagitis in pediatric patients. Expert Rev Gastroenterol Hepatol. 2025 Jan-Feb; 19(2):145-153.
-
Stein EJ, Mesenbring E, Smith T, Hebbe A, Salahuddin T, Waldo SW, Dyal MD, Doll JA. Intravascular Imaging as a Performance Measure for Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2025 Feb; 18(2):e014528.
-
Knight V. Phospho-flow cytometry assays for diagnostic use - A discussion of assay utility and assay development and validation challenges. J Immunol Methods. 2025 Feb; 537:113818.
-
Butala NM, Lalani C, Tale A, Song Y, Kolte D, Baron S, Strom J, Cohen DJ, Yeh RW. Use of Claims to Assess Outcomes and Treatment Effects in the Evolut Low Risk Trial. Circ Cardiovasc Interv. 2025 Jan; 18(1):e014592.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|